Michael McManus Jr Net Worth & Insider Trades

Michael McManus Jr - Director, Novavax Inc

As of June 21, 2022

What is Michael McManus Jr's Net Worth?

The current estimated net worth of Novavax Inc's Director, Michael McManus Jr, is estimated to be about $3.91M . Michael McManus Jr owns about 5,951 units of Novavax Inc common stock. In the last 18 years at Novavax Inc, Michael McManus Jr has sold an estimated value of $2.07M worth.

What is Michael McManus Jr's Past Insider Trading?

Michael McManus Jr's largest purchase order was 8,000 units , worth over $220.8K on August 20, 2020. Michael McManus Jr's largest sale order was 8,000 units , worth over $1.17M on August 20, 2020. In total, Michael McManus Jr has made about 24 transactions over 18 years of their time at Novavax Inc. Michael McManus Jr usually trades in March, with the busiest year in 2017. The most recent transaction was a sale order of 4,000 units , worth over $883.11K on March 23, 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Michael McManus Jr's' Mailing Address?

  • Mailing address is 241-02 Northern Blvd Douglaston NY 11362 NY

Novavax Inc Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Other Earnings Plans or Compensations
Stanley C. Erck Stanley C. Erck 2020 $657,181 $48,086,018 $44,115,244 $48,086,018 $11,400 $48,086,018
Stanley C. Erck Stanley C. Erck 2019 $642,720 $2,438,562 $986,660 $2,438,562 $11,200 $2,438,562
Stanley C. Erck Stanley C. Erck 2018 $638,040 $4,158,398 $3,509,358 $4,158,398 $11,000 $4,158,398
Gregory F. Covino 2020 $55,000 $1,417,774 $659,967 $1,417,774 $8,032 $1,417,774
Gregory F. Covino 2019 $― $― $― $― $― $―
Gregory F. Covino 2018 $― $― $― $― $― $―
Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. 2020 $483,443 $24,923,376 $22,859,741 $24,923,376 $11,400 $24,923,376
Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. 2019 $470,453 $1,875,198 $819,421 $1,875,198 $11,200 $1,875,198
Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. 2018 $460,125 $1,681,456 $1,131,189 $1,681,456 $11,000 $1,681,456
John J. Trizzino John J. Trizzino 2020 $415,892 $21,327,954 $19,819,717 $21,327,954 $11,400 $21,327,954
John J. Trizzino John J. Trizzino 2019 $390,701 $1,465,602 $584,103 $1,465,602 $9,546 $1,465,602
John J. Trizzino John J. Trizzino 2018 $378,078 $1,329,776 $890,700 $1,329,776 $7,500 $1,329,776
John A. Herrmann III John A. Herrmann III 2020 $402,842 $20,606,814 $18,924,907 $20,606,814 $11,400 $20,606,814
John A. Herrmann III John A. Herrmann III 2019 $378,591 $1,353,416 $488,397 $1,353,416 $11,200 $1,353,416
John A. Herrmann III John A. Herrmann III 2018 $362,695 $1,137,576 $712,560 $1,137,576 $11,000 $1,137,576
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1000694/000110465921060332/tm212692d3_def14a.htm

What are Novavax Inc's Past Insider Trades?

Novavax Inc's most recent insider trade came on April 4, 2022 by James Young who sold 12,500 units worth $919.76K . In the last 19 years, insiders at Novavax Inc have sold an estimated value of $286.8M and bought an estimated value of $38.15M worth of shares. Insider trading is most common in March, with the busiest year in 2021. The most active traders at the company are Gregory Glenn, President,  Gary Evans, Director,  and John A. Herrmann III, EVP .

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1